ConductScience.org, home

Gene · 4026

LPP: LIM domain containing preferred translocation partner in lipoma

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. LPP: LIM domain containing preferred translocation partner in lipoma. Genes, record 4026. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/4026

On this page

Gene

Symbol
LPP
HGNC
Name
LIM domain containing preferred translocation partner in lipoma
HGNC
NCBI Gene ID
4026
NCBI Gene
HGNC ID
HGNC:6679
HGNC
Ensembl
ENSG00000145012
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q93052Lipoma-preferred partner6120Ensembl, GeneID, HGNC

Source UniProt

Patents45

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1451730Q93052Espacenet
JP 2026004568 A2026-01-1451740Q93052Espacenet
EP 4650780 A22025-11-1918376Q93052Espacenet
EP 4640849 A22025-10-293676Q93052Espacenet
EP 4641201 A22025-10-2922836Q93052Espacenet
JP 2025519096 A2025-06-243676Q93052Espacenet
JP 2025517969 A2025-06-1222836Q93052Espacenet
JP 2025517970 A2025-06-1218376Q93052Espacenet
JP 2025032204 A2025-03-1130964Q93052Espacenet
JP 2025032204 A2025-03-1130965Q93052Espacenet

1 to 10 of 45

See all 45 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,170

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleLPP papersNewest fiscal year
P30CA016672Cancer Center Support Grant82025
P30CA008748Cancer Center Support Grant72025
P30CA086862Cancer Center Support Grant42025
P30CA125123Baylor College of Medicine Cancer Center - Cancer Center Support Grant42025
P30DK063491Diabetes Research Center (DRC)42025
P30CA023074University of Arizona Cancer Center - Cancer Center Support Grant32025
R01DK062370Identifying Genes for Type 2 Diabetes: FUSION32025
ZIADK069028Genetic Epidemiology of Diabetes and Obesity32025
ZIADK069071Structural Analysis Of Candidate Genes For Type 2 Diabetes and Obesity32025
K24AR069760Patient oriented research and mentoring program in dermatologic diseases22025

1 to 10 of 1,170Source NIH's project files

See all 1,170 nih grants

Papers1,409

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Designing nature's nanocarriers: advances and challenges in functionalizing bacterial extracellular vesicles.J Control Release202642753820PubTator, text miningPubMed
Exploratory Toxicogenomic Profiling Identifies Candidate DINCH-Responsive Genes Relevant to Prostate Cancer.Int J Mol Sci202642737583PubTator, text miningPubMed
CircARHGAP10 inhibits colorectal cancer cell proliferation, migration and invasion by governing the miR-29a-5p/LPP axis and regulating Wnt/β-catenin signaling pathway.Mol Cell Biochem202642701984PubTator, text miningPubMed
Engineered Bacterial Membranes as Next-Generation Platforms for Cancer Immunotherapy.Small Sci202642524337PubTator, text miningPubMed
Integrated scissor and CIBERSORTx analyses reveals fibroblast subpopulations and biomarkers in stomach adenocarcinoma.Discov Oncol202642455275PubTator, text miningPubMed
Genetic associations of eosinophilic granulomatosis with polyangiitis in the Japanese population: exploring similarities and differences with European populations.RMD Open202642431644PubTator, text miningPubMed
Identification and verification of immunogenic cell death-related signatures derived from bone metastasis of prostate cancer based on multi-omics and machine learning algorithms.Comput Biol Chem202642419189PubTator, text miningPubMed
Multi-omics profiling identifies HMGA2 fusions as defining a distinct and prognostically favorable subtype of dedifferentiated liposarcoma with rhabdomyosarcomatous differentiation.Hum Pathol202642250699PubTator, text miningPubMed
Genetic yield of targeted diagnostic screening in a large European cohort of 368 thoracic aortic dissection patients.Eur J Hum Genet202642236916PubTator, text miningPubMed
Clinical outcomes of pelvic floor muscle training, electrical stimulation, and magnetic stimulation in women with postpartum stress urinary incontinence: a retrospective cohort study.BMC Womens Health202642104361PubTator, text miningPubMed

1 to 10 of 1,409

See all 1,409 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/4026

GET https://conductscience.org/api/genes/v1/4026/patents?page=2